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Abstract
Background. Although cognitive-behavioural therapy (CBT) is a well-established treatment
for adult depression, its efficacy and efficiency may be enhanced by better understanding
its mechanism(s) of action. According to the theoretical model of CBT, symptom improve-
ment occurs via reductions in maladaptive cognition. However, previous research has not
established clear evidence for this cognitive mediation model.
Methods. The present study investigated the cognitive mediation model of CBT in the context
of a randomized controlled trial of CBT v. antidepressant medication (ADM) for adult depres-
sion. Participants with major depressive disorder were randomized to receive 16 weeks of CBT
(n = 54) or ADM (n = 50). Depression symptoms and three candidate cognitive mediators
(dysfunctional attitudes, cognitive distortions and negative automatic thoughts) were assessed
at week 0 (pre-treatment), week 4, week 8 and week 16 (post-treatment). Longitudinal asso-
ciations between cognition and depression symptoms, and mediation of treatment outcome,
were evaluated in structural equation models.
Results. Both CBT and ADM produced significant reductions in maladaptive cognition and
depression symptoms. Cognitive content and depression symptoms were moderately corre-
lated within measurement waves, but cross-lagged associations between the variables and
indirect (i.e. mediated) treatment effects were non-significant.
Conclusions. The results provide support for concurrent relationships between cognitive and
symptom change, but not the longitudinal relationships hypothesized by the cognitive
mediation model. Results may be indicative of an incongruence between the timing of
measurement and the dynamics of cognitive and symptom change.
Cognitive-behavioural therapy (CBT) for depression is among the most widely used and stud-
ied treatments for depression. Despite its demonstrated efficacy overall (Cuijpers et al., 2013),
clinical trials demonstrate that over one-third of depressed patients do not respond to CBT
(Leichsenring, 2001; DeRubeis et al., 2005b; Dimidjian et al., 2006). According to the cognitive
model of depression, negatively biased cognition contributes to the onset and maintenance of
depression (Beck et al., 1979; Clark et al., 1999). CBT is thought to improve depression symp-
toms by producing adaptive change in cognition. The hypothesized model of change, wherein
CBT interventions produce changes in cognition, which in turn ameliorate depression symp-
toms, is termed the cognitive mediation model of CBT.
Evidence for the cognitive mediation model of CBT
Mediation models seek to explain how an effective treatment leads to symptom improvement
(Kraemer et al., 2002; MacKinnon et al., 2007). A variable that mediates treatment outcome is
intermediate in the causal path from the treatment to the outcome (MacKinnon, 2008). A
mediator of treatment suggests a possible mechanism of action, which may then be targeted
in the development of more potent and/or efficient treatments (Kraemer et al., 2002).
Demonstration of statistical mediation of treatment outcome requires a significant indirect
effect of treatment condition on the outcome, where the indirect effect is the product of:
(a) the effect of treatment condition on the mediator (‘a’ path) and; (b) the effect of the medi-
ator on the outcome, controlling for the effect of treatment condition on the outcome (‘b’ path;
Baron and Kenny 1986; MacKinnon et al., 2007).
Mediation specifies a temporal order, such that change in the mediator follows the initi-
ation of treatment and precedes change in the outcome. The full temporal ordering of vari-
ables cannot be specified in cross-sectional designs and prospective designs with only two
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measurement points, and must instead be assumed (Cole and
Maxwell, 2003). Maxwell and Cole (2007) demonstrated that tem-
poral assumptions are often erroneous and cross-sectional tests of
longitudinal mediation processes produce substantially biased
parameter estimates. Longitudinal mediation analysis with three
or more measurement points allow tests of the effects of treatment
condition on change in the mediator at a later time point (‘a’
path) and of change in the mediator on change in the outcome
at a later time point (‘b’ path; Cole and Maxwell, 2003;
MacKinnon, 2008). The indirect, or mediated, effect in longitu-
dinal analysis is similarly given by the product ‘ab’; however,
given that the mediator and outcome are measured at repeated
time points, there can be more than one ‘a’ path and ‘b’ path,
and thus more than one indirect effect (‘ab’) evaluated for
significance.
Empirical support exists for individual components of the cog-
nitive mediation model of CBT. CBT leads to increased use of
cognitive restructuring and other CBT skills, as well as decreased
negative automatic thoughts and dysfunctional attitudes (see
Garratt et al., 2007; Lorenzo-Luaces et al., 2015; Oei and Free,
1995, for reviews). CBT thus has a demonstrated effect on the
mediator (i.e. cognition), which is one component of the model.
Some researchers have argued that a fundamental assumption
of the cognitive mediation model is that cognitive change is spe-
cific to CBT, and CBT should, therefore, have a greater effect on
cognition than other treatments that presumably work via alter-
native mechanisms (Whisman, 1993; Garratt et al., 2007). In gen-
eral, this specificity hypothesis has not been supported. The
magnitude of cognitive change is similar across CBT and other
psychotherapies for depression (Oei and Free, 1995; Garratt
et al., 2007; Lorenzo-Luaces et al., 2015). Garratt et al. (2007)
argued that cognition is likely directly or indirectly targeted by
other psychotherapies, and the specificity hypothesis may be
best evaluated by contrasting CBT and pharmacotherapy, as cog-
nitive change may occur in pharmacotherapy but is not thought
to be the mechanism of symptom improvement. Comparisons
of CBT and pharmacotherapy have yielded mixed evidence,
with some studies reporting greater cognitive change in CBT
(e.g. Ma and Teasdale, 2004; Fresco et al., 2007; Dozois et al.,
2009) and others reporting no differences between treatments
(DeRubeis et al., 1990; Quilty et al., 2008, 2014; Fournier et al.,
2013).
There is also evidence for the second component of the model,
namely the association between the mediator (i.e. cognition) and
outcome, although mostly in the form of concurrent associations.
Several studies have found that cognitive change and symptom
change co-vary over the course of CBT for depression (Oei and
Free, 1995; Garratt et al., 2007; Lorenzo-Luaces et al., 2015).
However, it is necessary to establish the temporal precedence of
cognitive change to rule out the possibilities that change in
depression symptoms precedes change in cognition or that
changes occur simultaneously. A few studies have distinguished
concurrent and temporal relationships between cognitive and
symptom change, and have found strong evidence for concurrent
but not temporal relationships (Warmerdam et al., 2010; Vittengl
et al., 2014; Lemmens et al., 2017; but see DeRubeis et al., 1990).
Psychotherapy research has only recently begun to incorporate
advances in statistical mediation research, including longitudinal
designs and analyses (Lemmens et al., 2016). The few studies
that have evaluated temporal order have found null or weak
evidence for the cognitive mediation model of CBT for depression
(Vittengl et al., 2014; Lemmens et al., 2017). Using latent
difference score models, Lemmens et al. (2017) did not observe
indirect effects of cognitive v. interpersonal therapy on change
in depression symptoms via changes in any of the examined med-
iators (dysfunctional attitudes, interpersonal problems, rumin-
ation, self-esteem and therapeutic alliance). Vittengl et al.
(2014) evaluated temporal relationships between change in cogni-
tive variables (dysfunctional attitudes, attributions for negative
events, hopelessness and positive coping) and change in depres-
sion symptoms during cognitive therapy in a large sample of out-
patients with recurrent major depressive disorder (MDD).
Structural equation models (SEMs) provided weak evidence for
cross-lagged relations in which cognitive change precedes symp-
tom change and vice versa.
The current study
The current study incorporated contemporary recommendations
for research on mediation models of psychotherapy (Lorenzo-
Luaces et al., 2015; Lemmens et al., 2016) to evaluate the cognitive
mediation model of CBT for depression. Pharmacotherapy was
used as a comparison treatment to test the specificity of cognitive
change and mediation to CBT. Longitudinal SEM was used to
evaluate reciprocal relationships between multiple candidate cog-
nitive mediators and depression symptoms (MacKinnon, 2008).
Dysfunctional attitudes, cognitive distortions and negative auto-
matic thoughts were selected as the candidate mediators based
on their relevance to cognitive theory and the CBT protocol for
depression (Beck et al., 1979) and use in previous cognitive medi-
ation research (e.g. DeRubeis et al., 1990; Quilty et al., 2008;
Vittengl et al., 2014; Lemmens et al., 2017). The following
hypotheses were made based on the cognitive mediation model:
(1) CBT would lead to greater change in the cognitive variables
than pharmacotherapy; (2) the cognitive variables would predict
depression symptoms at subsequent time points; and (3) there
would be a significant indirect (i.e. mediated) effect of treatment
condition on depression symptoms via change in the cognitive vari-
ables (i.e. a significant mediated effect). The data for this study are
from a randomized controlled trial (RCT) of CBT v. pharmacother-
apy for adult depression (Quilty et al., 2014)†1.
Methods
Participants
The sample consisted of 104 participants with a primary diagno-
sis of MDD (53% female; mean age = 33.61 years, S.D. = 9.97).
Eligibility was based on the diagnostic criteria from the
Diagnostic and Statistical Manual of Mental Disorders – Fourth
Edition (DSM-IV; APA, 1994) and determined with the
Structured Clinical Interview for DSM-IV (SCID-IV; First et al.,
1995). Participants were required to be between 18 and 65 years
inclusive, fluent in English and capable of giving informed con-
sent. Exclusion criteria included a diagnosis of bipolar disorder,
psychotic disorder, substance dependence or organic brain syn-
drome; current treatment with antidepressant medications
(ADMs); or electroconvulsive therapy in the past 6 months.
Participants were randomized to a CBT (n = 54) or antidepres-
sant (ADM) condition (n = 50). Forty-nine participants in CBT
and 43 participants in ADM completed at least 8 weeks of treat-
ment. Participants self-identified according to the following
†The notes appear after the main text.
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Statistics Canada ethno-racial groupings: Caucasian (69.2%),
South Asian (15.4%), Black (5.5%), Visible Minority (3.3%),
Chinese (2.2%), Latin American (2.2%), Arab/West Indian
(1.1%) and Aboriginal (1.1%).
Measures
Depression symptoms
The primary outcome was depression symptoms as measured by
the Hamilton Depression Rating Scale (HAM-D; Hamilton, 1960).
The HAM-D is a 17-item semi-structured interview that assesses
depression symptom severity over the past week. The HAM-D
was selected as the primary outcome because it is interviewer-
administered and consists of less cognitive content than com-
monly used self-report measures including the Beck Depression
Inventory – Second Edition (BDI-II; Beck et al., 1996). These
properties are preferable in assessing relationships between
depression symptoms and cognitive content (see immediately
below) because shared variance due to assessment method and
overlapping item content is minimized. Cronbach’s α values for
the HAM-D in the present sample were 0.69 at week 0, 0.77 at
week 4, 0.83 at week 8 and 0.86 at week 16.
Cognitive content
The Dysfunctional Attitudes Scale (DAS; Weissman and Beck,
1978) consists of 40 items that measure depressotypic attitudinal
statements. Respondents rate their agreement with each state-
ment. The DAS showed high internal consistency in the present
sample at each assessment point (Cronbach’s α = 0.92–0.94).
The Cognitive Distortions Scale (CDS; Covin et al., 2011) con-
sists of 20 items that measure 10 cognitive errors that were ini-
tially described by Burns (1980) and are commonly discussed in
CBT protocols. Respondents indicate how frequently they make
each type of error in interpersonal and achievement situations.
The CDS showed high internal consistency in the present sample
at each assessment point (Cronbach’s α = 0.91–0.96).
The Automatic Thoughts Questionnaire–Negative (ATQ-N;
Hollon and Kendall, 1980) consists of 30 items that measure
negative automatic thoughts. Respondents indicate the frequency
of negative automatic thoughts during the past week. The ATQ-N
showed high internal consistency in the present sample at each
assessment point (Cronbach’s α = 0.96–0.98).
Procedure
Participants were randomly assigned to 16 weekly sessions of CBT
administered according to the protocol outlined by Beck et al.
(1979) or 16 weeks of ADM according to Canadian Network
for Mood and Anxiety Treatment (CANMAT) guidelines (Lam
et al., 2009). CBT was provided by nine study clinicians, including
three licensed clinical psychologists and six doctoral-level trainees.
ADM was provided by four psychiatrists. Depression symptoms
and cognitive content were measured at week 0 (pre-treatment),
week 4, week 8 and week 16 (post-treatment). Additional details
about the original RCT are reported in Quilty et al. (2014).
Statistical analyses
All models were tested using maximum likelihood estimation
in Mplus Version 8.1 (Muthén and Muthén, 1998–2017).
Bootstrapping with 5000 samples was used to compute standard
errors. Model fit was evaluated using the model χ2 test, with non-
significant χ2 values indicating good model fit, the Comparative Fit
Index (CFI), with values ⩾0.95 indicating close model fit, the Root
Mean Square Error of Approximation (RMSEA), with values ⩾0.10
indicating poor model fit, and the Standardized Root Mean Square
Residual (SRMR), with values ⩽0.08 indicating acceptable fit. The
Akaike Information Criterion (AIC) was used to compare alterna-
tive models, with lower values indicating better fit.
Four-wave (week 0, week 4, week 8, week 16) cross-lagged
SEMs were estimated to evaluate the longitudinal relationships
between treatment condition (dummy-coded 1 for the CBT con-
dition and 0 for the ADM condition), the cognitive variables
(DAS, CDS and ATQ-N) and depression symptoms as measured
by the HAM-D (Cole and Maxwell, 2003; MacKinnon, 2008). An
advantage of cross-lagged panel models is that all of the effects
relevant to mediation (i.e. ‘a’ paths, ‘b’ paths and ‘ab’ product
term) are modelled and tested simultaneously. For each cognitive
variable, a model including all cross-lagged paths between the
cognitive variable and depression symptoms was specified
(Fig. 1; MacKinnon, 20082). Although testing the cognitive medi-
ation hypothesis (i.e. mediation of treatment condition on depres-
sion symptoms via change in the cognitive variables) was of
primary interest, a model that included all cross-lagged paths
between the cognitive variable and depression symptoms was
more conceptually plausible than assuming paths from depression
symptoms to the cognitive variable are zero, given effects of
depressed mood on cognition (e.g. Miranda and Persons, 1988;
Fresco et al., 2006). Autoregressive relations between the same
variable at adjacent waves were included, as well as covariances
or residual covariances among the variables within each measure-
ment wave. Measurement error was corrected for in the models by
using latent variables with single indicators for each variable, and
fixing the variance of the indicator variables to a, where a = (1−
reliability) × variance for each variable (see Fig. 1; Muthén and
Muthén, 1998–2017). Reliability was estimated using each vari-
able’s Cronbach’s α value.
The assumption of equivalence of cross-lagged relationships
between each cognitive variable and depression symptoms across
the ADM and CBT groups was tested in two-group models. To
provide an additional test of the significance of the cross-lagged
paths between the cognitive variables and depression symptoms,
the fit indices of cross-lagged models were compared with those
of models that included only autoregressive relations between
the same variables at adjacent measurement waves and covar-
iances or residual covariances between variables within the
same measurement wave.
Indirect (i.e. mediated) effects and their standard errors and
bias-corrected bootstrap 95% confidence intervals (CIs) were
computed for all longitudinal indirect effects between the treat-
ment condition, the cognitive variable and depression symp-
toms. Thus, eight indirect effects were tested for each model.
Four reflected the cognitive mediation model, with the cogni-
tive variable (M) mediating the effect of treatment condition
(X) on depression symptoms (Y): (1) X → week 4 M → week
8 Y; (2) X → week 8 M → week 16 Y; (3) X → week 4 M →
week 8 M → week 16 Y; and (4) X → week 4 M → week 8 Y
→ week 16 Y. The other four indirect effects were the same
as above but reflected the reverse mediation model, with
depression symptoms mediating the effect of treatment condi-
tion on the cognitive variable. Note that each of the indirect
effects represents an ‘ab’ product term, wherein the ‘a’ path is
the effect of X on M and the ‘b’ path is the effect of M on Y,
controlling for the effect of X on Y.
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Results
Descriptive statistics
Table 1 presents the mean scores on the DAS, CDS, ATQ-N and
HAM-D for the ADM and CBT conditions at each measurement
wave. Participants in both conditions showed significant
decreases on each of the cognitive variables and depression
symptoms over the treatment period. Bivariate correlations
between the raw study measures are reported in the online
Supplementary Appendix.
Longitudinal models
The fit indices for the DAS, CDS and ATQ-N cross-lagged mod-
els indicated good fit to the data (Table 2). Standardized param-
eter estimates and standard errors from the three models are
Fig. 1. Cross-lagged panel model of concurrent and longitudinal relationships between treatment condition, the cognitive variable and depression symptoms as
measured by the Hamilton Depression Rating Scale (HAM-D), correcting for measurement error.
Table 1. Mean scores on the cognitive variables and HAM-D at each wave of measurement in the ADM and CBT groups
Variable
Week 0
(pre-treatment) Week 4 Week 8
Week 16
(post-treatment) Within-groups F p
Partial
η2
HAM-D
ADM 16.42 (5.33) 10.84 (5.88) 9.74 (6.50) 8.50 (6.51) 31.14 <0.001 0.46
CBT 16.79 (5.00) 14.71 (5.26) 12.29 (6.45) 7.43 (6.01) 41.20 <0.001 0.48
DAS
ADM 153.18 (32.19) 142.88 (27.82) 139.14 (35.50) 135.00 (33.01) 4.68 0.014 0.12
CBT 162.98 (33.16) 158.02 (35.66) 148.27 (34.33) 134.11 (33.89) 21.03 <0.001 0.32
CDS
ADM 84.16 (18.93) 77.40 (20.94) 73.79 (24.63) 71.39 (26.27) 5.28 0.004 0.13
CBT 94.56 (20.29) 91.22 (19.56) 86.98 (20.02) 77.78 (24.54) 12.22 <0.001 0.22
ATQ-N
ADM 92.96 (24.21) 73.49 (29.52) 71.81 (32.69) 65.51 (32.40) 12.53 <0.001 0.26
CBT 99.28 (25.28) 93.84 (26.34) 80.69 (27.38) 61.28 (25.25) 41.78 <0.001 0.49
HAM-D, Hamilton Depression Rating Scale; DAS, Dysfunctional Attitudes Scale; CDS, Cognitive Distortions Scale; ATQ-N, Automatic Thoughts Questionnaire – Negative.
Standard deviations are in parentheses.
At week 0, data were missing for n = 1 (1 × CBT) for the HAM-D. At week 4, data were missing for n = 10 (7 × ADM, 3 × CBT) for the HAM-D, and n = 11 (7 × ADM, 4 × CBT) for the DAS, CDS, and
ATQ-N. At week 8, data were missing for n = 13 (8 × ADM, 5 × CBT) for the HAM-D, DAS, CDS, and ATQ-N. At week 16, data were missing for n = 20 (12 × ADM, 8 × CBT) for the HAM-D and DAS, n =
21 (12 × ADM, 9 × CBT) for the CDS, and n = 21 (13 × ADM, 8 × CBT) for the ATQ-N.
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displayed in Table 33. There was a moderate to high stability of the
cognitive variables (β = 0.64–0.87) and depression symptoms (β =
0.54–0.92), across measurement waves, as well as significant cor-
relations between the cognitive variables and depression symp-
toms within each measurement wave (r = 0.29–0.82)4. Wald
tests within two-group models indicated no significant difference
in the magnitude of the cross-lagged paths across the ADM and
CBT conditions, for all three models, all p > 0.05. Thus, the
assumption of equivalence of the cross-lagged paths across the
CBT and ADM conditions was met, which justifies the use of
the cross-lagged models that included participants in both treat-
ment conditions and modelled treatment condition as a two-level
predictor variable (as depicted in Fig. 1).
Hypothesis 1: CBT would lead to greater change in the cognitive
variables than pharmacotherapy
Treatment condition was a significant predictor of cognition at
week 4 for the DAS and ATQ-N, and a marginally significant pre-
dictor of the CDS at week 4 (Table 3; a1 paths). However, the dir-
ection of this effect was opposite to hypothesis, as participants in
the ADM condition reported lower maladaptive cognition
(Table 3, a1 paths). At week 16, the direction of the effect
reversed, and participants in the CBT condition had lower levels
of maladaptive cognition, although this effect was only marginally
significant for the CDS model again (Table 3; a3 paths). Similarly,
participants in the ADM condition had significantly lower
depression symptoms at week 4 (Table 3; a4 paths), but higher
symptoms at week 16 (Table 3; a6 paths), relative to participants
in the CBT condition.
Hypothesis 2: the cognitive variables would predict depression
symptoms at subsequent time points
The cognitive variables did not significantly predict depression
symptoms at subsequent time points, as the cross-lagged paths
from the cognitive variable to depression symptoms were non-
significant in the three models (Table 3; b1, b2, b3 paths). The
reverse b paths in all three models (i.e. prediction of subsequent
maladaptive cognition by depression symptoms) were also non-
significant (Table 3; b4, b5, b6 paths). In addition, autoregressive
models that eliminated the cross-lagged paths did not result in a
significant increase in model misfit for each model (see Table 2),
providing additional evidence for the lack of longitudinal relation-
ships between the cognitive variables and depression symptoms.
Hypothesis 3: there would be a significant indirect effect of
treatment condition on depression symptoms via change in the
cognitive variables (i.e. a significant mediated effect)
All longitudinal indirect (i.e. mediated) effects of treatment con-
dition on depression symptoms via cognition, and on cognition
via depression symptoms, were non-significant for all three mod-
els (Table 4).
Discussion
This study evaluated the cognitive mediation model of CBT for
depression in the context of an RCT of CBT v. ADM. SEM was
used to evaluate concurrent and longitudinal associations between
depression symptoms and three forms of maladaptive cognition
relevant to cognitive models of depression aetiology and treat-
ment (Beck et al., 1979), namely dysfunctional attitudes, cognitive
distortions and negative automatic thoughts. There were signifi-
cant concurrent, but not longitudinal, relationships between cog-
nition and depression symptoms. Longitudinal indirect (i.e.
mediated) effects were non-significant, such that the cognitive
variables did not mediate the effect of treatment on depression
symptoms and depression symptoms did not mediate the effect
of treatment on cognition.
Effect of treatment condition on cognition and depression
symptoms
Participants in both the CBT and ADM conditions demonstrated
a significant reduction in depression symptoms and maladaptive
cognition over the 16 weeks of treatment. Mixed support was
found for the hypothesis that CBT would lead to greater change
in the cognitive variables than pharmacotherapy. Change in cog-
nition occurred earlier in the ADM condition than the CBT con-
dition, as indicated by group differences at week 4. By the end of
treatment, the pattern shifted and levels of maladaptive cognition
were lower in the CBT condition. However, these effects were
small, and they were only marginally significant for the CDS
model. This pattern of findings parallels that observed for depres-
sion symptoms.
ADM thus appears to produce changes in depression-relevant
cognition, at a near-comparable level to CBT. Although this find-
ing contradicts the specificity hypothesis, it is consistent with
prior studies that have not found differences in cognitive change
in CBT v. pharmacotherapy (DeRubeis et al., 1990; Quilty et al.,
Table 2. Model fit indices for the longitudinal mediation and autoregressive models involving the DAS, CDS and ATQ-N
Model df χ2 p(χ2) CFI RMSEA Pclose SRMR AIC
Cross-lagged models
Model 1: DAS cross-lagged model 14 19.586 0.144 0.987 0.062 0.342 0.043 5655.79
Model 2: CDS cross-lagged model 14 19.412 0.150 0.987 0.061 0.351 0.064 5379.49
Model 3: ATQ-N cross-lagged model 14 13.300 0.503 1.000 0.000 0.727 0.043 5503.43
Autoregressive models
Model 4: DAS autoregressive model 20 25.806 0.172 0.987 0.053 0.430 0.060 5650.01
Model 5: CDS autoregressive model 20 22.533 0.312 0.994 0.035 0.600 0.074 5370.61
Model 6: ATQ-N autoregressive model 20 16.634 0.677 1.000 0.000 0.874 0.057 5494.76
DAS, Dysfunctional Attitudes Scale; CDS, Cognitive Distortions Scale; ATQ-N, Automatic Thoughts Questionnaire – Negative.
Models are corrected for measurement error.
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2008, 2014; Fournier et al., 2013). It is possible that cognitive
change occurred in the ADM condition subsequent to reductions
in depression symptoms produced via a biochemical mechanism.
In support of this notion, robust concurrent relationships between
cognitive and symptom change were observed. A potential
explanation for the lack of longitudinal relationship observed is
that the majority of change in both depression symptoms and
cognition occurred in the first 4 weeks of treatment in the
ADM condition, and any temporal relations during this period
would be unobserved.
Garratt et al. (2007) argued that although pharmacotherapy
may lead to reductions in maladaptive cognition, these reduc-
tions may be more superficial and unstable than the cognitive
change produced by CBT. They referred to studies by Segal
et al. (1999, 2006) that found that dysfunctional attitudes
decreased similarly in depressed patients treated with CBT and
pharmacotherapy, but patients treated with pharmacotherapy
had greater negative cognition in response to induced negative
mood than patients treated with CBT. This cognitive reactivity
to depressed mood, in turn, was associated with a higher rate
of relapse. It would be valuable to replicate this finding in future
studies that include a post-treatment mood induction and/or
follow-up period.
Association between change in cognition and change in
depression symptoms
Evidence for concurrent but not longitudinal associations between
cognitive and symptom change is consistent with prior research
(e.g. Warmerdam et al., 2010; Vittengl et al., 2014; Lemmens
et al., 2017). Several explanations for the lack of longitudinal rela-
tionships are possible. As argued by others (Burns and Spangler,
2001; Vittengl et al., 2014), some unknown mechanism may have
caused simultaneous change in both cognition and depression
symptoms. Depression-relevant constructs such as low self-
esteem, hopelessness and cognitive networks or schemas have
been proposed as candidates (Burns and Spangler, 2001), but
extant evidence does not support their role as mediators or tem-
poral predictors of symptom change (Quilty et al., 2014; Vittengl
et al., 2014; Lemmens et al., 2017). One might also posit the
therapeutic alliance, therapist empathy or homework compliance
(‘common factors’, cf. Rosenzweig, 1936) as common causes of
cognitive and symptom change. However, although common
treatment factors have been shown to predict outcome
(Castonguay et al., 1996), these variables have not been found
to mediate outcome in CBT (Burns and Spangler, 2001;
Lemmens et al., 2017), and the mechanisms by which they may
relate to outcome are unclear (DeRubeis et al., 2005a).
Table 3. Standardized parameter estimates (with standard errors in parentheses) for the cross-lagged structural equation models involving the DAS, CDS and ATQ-N
Model 1: DAS Model 2: CDS Model 3: ATQ-N
Treatment condition predicts cognitive variable (a paths) a1 0.30* (0.15) 0.32† (0.18) 0.57* (0.16)
a2 −0.15 (0.12) −0.01 (0.14) −0.25 (0.17)
a3 −0.30* (0.14) −0.28† (0.15) −0.34* (0.16)
Treatment condition predicts depression symptoms (reverse a paths) a4 0.73* (0.19) 0.69* (0.20) 0.75* (0.19)
a5 −0.18 (0.22) −0.17 (0.23) −0.16 (0.22)
a6 −0.47* (0.19) −0.49* (0.19) −0.49* (0.19)
Cross-lagged paths: cognitive variable predicts depression symptoms
(b paths)
b1 0.20 (0.13) 0.15 (0.14) 0.05 (0.14)
b2 −0.14 (0.11) −0.11 (0.15) −0.11 (0.22)
b3 −0.07 (0.09) −0.03 (0.11) 0.01 (0.16)
Cross-lagged paths: depression symptoms predict cognitive variable
(reverse b paths)
b4 −0.06 (0.08) −0.05 (0.12) −0.06 (0.11)
b5 0.05 (0.08) 0.10 (0.10) 0.21 (0.16)
b6 −0.08 (0.13) 0.01 (0.09) 0.05 (0.17)
Auto-regressive paths: stability of cognitive variable over time
(xx paths)
xx1 0.85* (0.05) 0.78* (0.08) 0.71* (0.09)
xx2 0.87* (0.06) 0.82* (0.08) 0.64* (0.16)
xx3 0.80* (0.08) 0.86* (0.08) 0.71* (0.12)
Auto-regressive paths: stability of depression symptoms over time
(yy paths)
yy1 0.55* (0.14) 0.54* (0.14) 0.55* (0.16)
yy2 0.92* (0.11) 0.91* (0.14) 0.91* (0.21)
yy3 0.81* (0.12) 0.80* (0.14) 0.78* (0.20)
Concurrent associations between cognitive variable and depression symptoms
(xy paths)
xy1 0.29* (0.12) 0.36* (0.11) 0.49* (0.09)
xy2 0.37* (0.17) 0.45* (0.17) 0.82* (0.12)
xy3 0.82* (0.38) 0.50* (0.44) 0.75* (0.21)
xy4 0.58* (0.19) 0.31* (0.31) 0.79* (0.24)
DAS, Dysfunctional Attitudes Scale; CDS, Cognitive Distortions Scale; ATQ-N, Automatic Thoughts Questionnaire – Negative.
*p < 0.05; †p < 0.10. Bold type indicates paths predicted by the cognitive mediation model. Models are corrected for measurement error. Standardized parameter estimates are reported.
STDXY estimates are reported for parameter estimates with continuous covariates (all effects except a1–a6) and STDY estimates are reported for parameter estimates with binary covariates
(a1–a6; Muthén and Muthén, 1998–2017). The standardized coefficient for STDXY standardization is interpreted as the change in y standard deviation units for a standard deviation change in
x. The standardized coefficient for STDY standardization is interpreted as the change in y standard deviation units for the CBT relative to ADM condition.
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It is possible that the timing of measurement precluded detec-
tion of cognitive mediation of symptom outcome. If the dynamics
of cognitive and symptom change occur on a more rapid scale
than the timing of measurement, then mediation will not be
observed. Variables were assessed earlier in treatment and at
shorter intervals in the present study than previously (e.g.
Vittengl et al., 2014; Lemmens et al., 2017), but even more fre-
quent measurement (e.g. weekly) may be required. Another com-
pelling possibility is that the timing of change in cognition and
symptoms, and the temporal relationship between these variables,
varies across individuals. For some individuals, treatment-related
change in cognition and symptoms may occur quickly and/or be
tightly coupled in time, whereas for others changes may occur
slowly and/or be further related in time. Measurement approaches
that allow for between-subject variability in the temporal dynam-
ics of cognitive and symptom change and mediation of change
(i.e. ecological momentary assessment) may therefore be prefer-
able. In RCTs comparing psychotherapies, hypothesized cognitive
mediators may also be assessed on a session-by-session basis via
independent ratings of session audiotapes.
ADM was selected as a comparison treatment in this study to
provide a stringent test of the specificity of cognitive change and
Table 4. Longitudinal indirect (i.e. mediated) effects for the cross-lagged structural equation models involving the DAS, CDS and ATQ-N
Indirect effect Estimate S.E. p 95% CI
Model 1: DAS cross-lagged model
Mediation model
X → week 4 M → week 8 Y −0.25 0.25 0.307 −0.96, 0.05
X → week 8 M → week 16 Y 0.06 0.11 0.597 −0.08, 0.43
X → week 4 M → week 8 M → week 16 Y −0.10 −0.17 0.560 −0.58, 0.11
X → week 4 M → week 8 Y → Week 16 Y −0.20 0.20 0.749 −0.80, 0.04
Reverse mediation model
X → week 4 Y → week 8 M 1.25 2.15 0.562 −1.97, 6.85
X → week 8 Y → week 16 M 0.47 1.28 0.712 −0.90, 5.59
X → week 4 Y → week 8 Y → week 16 M −1.75 2.99 0.558 −8.87, 3.26
X → week 4 Y → week 8 M → week 16 M 0.96 1.68 0.567 −1.54, 5.30
Model 2: CDS cross-lagged model
Mediation model
X → week 4 M → week 8 Y −0.20 0.29 0.503 −1.22, 0.20
X → week 8 M → week 16 Y 0.00 0.10 0.980 −0.31, 0.26
X → week 4 M → week 8 M → week 16 Y −0.05 0.20 0.812 −0.58, 0.24
X → week 4 M → week 8 Y → week 16 Y −0.15 0.23 0.500 −0.83, 0.15
Reverse mediation model
X → week 4 Y → week 8 M 1.50 1.79 0.402 −1.36, 6.06
X → week 8 Y → week 16 M −0.03 0.62 0.964 −1.83, 1.00
X → week 4 Y → week 8 Y → week 16 M 0.10 1.44 0.943 −2.77, 3.17
X → week 4 Y → week 8 M → week 16 M 1.43 1.75 0.416 −1.22, 5.98
Model 3: ATQ-N cross-lagged model
Mediation model
X → week 4 M → week 8 Y −0.36 0.79 0.644 −2.44, 0.80
X → week 8 M → week 16 Y −0.02 0.30 0.953 −0.83, 0.46
X → week 4 M → week 8 M → week 16 Y 0.03 0.36 0.944 −0.73, 0.78
X → week 4 M → week 8 Y → week 16 Y −0.27 0.59 0.642 −1.77, 0.65
Reverse mediation model
X → week 4 Y → week 8 M 4.56 4.04 0.258 −0.67, 15.31
X → week 8 Y → week 16 M −0.24 1.30 0.856 −3.86, 1.60
X → week 4 Y → week 8 Y → week 16 M 1.00 3.46 0.772 −6.88, 7.16
X → week 4 Y → week 8 M → week 16 M 3.07 3.03 0.310 −0.38, 12.00
DAS, Dysfunctional Attitudes Scale; CDS, Cognitive Distortions Scale; ATQ-N, Automatic Thoughts Questionnaire – Negative; X, treatment condition; M, the candidate cognitive mediator (DAS,
CDS, or ATQ-N); Y, depression symptoms (Hamilton Depression Rating Scale; HAM-D).
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mediation to CBT. Given that one component of the test of medi-
ation is the effect of treatment condition on the mediator, it will
be more difficult to detect mediation in an RCT if both treatment
conditions produce similar effects on the hypothesized mediator.
Future studies of cognitive mediation in CBT may include both an
appropriate comparison treatment to test specificity, as well as a
control condition that is expected to have a weaker effect on cogni-
tion than CBT (e.g. supportive therapy) to provide a more powerful
overall test of mediation. It should be noted that the similar effects
of the treatment conditions on cognition do not account for the
lack of longitudinal relationships between cognition and depression
symptoms observed in this study, as discussed above.
Study limitations and conclusions
A limitation of this study was the sample size, which, although
relatively large for a psychotherapy trial, was modest for medi-
ation analysis. A larger sample would enhance the precision
and reliability of the findings, as well as the power of the study
to detect small effects (such as the effect of treatment condition
on the CDS, which was only marginally significant at week 4
and week 16). Another notable limitation is the lack of a
follow-up assessment, which precluded evaluation of the stability
of cognitive and symptom change following ADM and CBT. It
would be particularly interesting to evaluate whether cognitive
change over treatment differentially predicts relapse to depression
for participants treated with ADM v. CBT, and/or whether cogni-
tive reactivity to depressed mood differs between the conditions at
post-treatment and is predictive of relapse. The candidate cogni-
tive mediators examined in this study were selected because they
are central constructs in cognitive theory of depression and tar-
geted in CBT protocols (Beck et al., 1979). The selected measures
of these constructs have established psychometric properties and
have been used in previous investigations of cognitive mediation,
which allowed for comparison with extant findings (e.g. DeRubeis
et al., 1990; Quilty et al., 2008; Vittengl et al., 2014; Lemmens
et al., 2017). Future research may evaluate other cognitive con-
structs (e.g. rumination, self-esteem, attributions) and/or alterna-
tive measures that may have greater utility or specificity as
mediators of CBT outcome. It is also possible that the relationship
between CBT and change in cognition is itself mediated by treat-
ment variables such as homework completion. Future studies that
assess treatment variables, cognition and depression symptoms at
multiple time points would be able to test these complex relation-
ships. Finally, the internal consistency of the HAM-D was lower at
week 0 compared with later assessment points; however, unreli-
ability was corrected for in the SEMs which improves the accuracy
of parameter estimates (e.g. Goldsmith et al., 2018).
To conclude, the present study investigated the cognitive medi-
ation model of CBT using a longitudinal mediation analysis. Both
CBT and ADM produced significant reductions in maladaptive
cognition and depression symptoms. There was robust evidence
for concurrent but not the hypothesized longitudinal relationships
between cognitive and symptom change. Future research on med-
iators of psychotherapy outcome may benefit from using measure-
ment approaches that allow for more frequent assessment and
between-subject variability in the temporal dynamics of change.
Notes
1 Quilty et al. (2014) reported on cognitive structure and processing in CBT v.
pharmacotherapy; the current investigation focused on cognitive content as a
potential mediator of outcome across the two therapies.
2 The reader is referred to MacKinnon (2008) for further information on lon-
gitudinal SEMs that may be applied in longitudinal mediation analysis.
3 STDXY estimates are reported for parameter estimates with continuous cov-
ariates and STDY estimates are reported for parameter estimates with binary
covariates (Muthén and Muthén, 1998–2017). The standardized coefficient
for STDXY standardization is interpreted as the change in y standard deviation
units for a standard deviation change in x. The standardized coefficient for
STDY standardization is interpreted as the change in y standard deviation
units for the CBT relative to ADM condition.
4 The cross-lagged models were also estimated with participant age and bio-
logical sex included as covariates. The inclusion of these covariates did not
change the results substantively but resulted in reduced model fit relative to
the original models. Thus, the results of the original models without the cov-
ariates are reported.
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